Semaglutide belongs to a group of compounds known as Glucagon-like Peptide 1 Receptor Agonists. It mimics the role of the GLP-1 hormone which is naturally occurring in the human body and is released when we consume food. Because Semaglutide functions like GLP-1 it decreases blood sugar levels and suppresses appetite. Consequently, it is prescribed by physicians to patients suffering from both Diabetes and Obesity. Clinical studies show that Semaglutide also increases metabolism, reduces visceral fat and improves blood lipids. It has also been shown to prevent heart and kidney disease.